# To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migrane Headaches

> **NCT00434083** · PHASE3 · COMPLETED · sponsor: **POZEN** · enrollment: 1200 (—)

## Conditions studied

- Migraine Headaches

## Interventions

- **DRUG:** sumatriptan
- **DRUG:** naproxen sodium

## Key facts

- **NCT ID:** NCT00434083
- **Lead sponsor:** POZEN
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** —
- **Final completion:** 2005-01
- **Target enrollment:** 1200 (—)
- **Last updated:** 2007-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00434083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00434083, "To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migrane Headaches". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT00434083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*